Skip to main content

Table 1 Previous reported cases of RA-TPE against primary rectal cancer

From: Robot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report

References (published year)

Age

Sex

BMI

Preoperative radiation

Neoadjuvant chemotherapy

Robot generation

Operative duration (min)

Amount of blood loss (ml)

T§

N§

M§

Stage§

RM (mm)

Complications (Clavien–Dindo classification)

Hospital stay after surgery (days)

Recurrence

Follow-up period (months)

Shin JW. (2014) [12]

41

M

18.0

Yes

Yes

NA

480

300

cT4b

N2

M0

cIIIC

NA

None

8

NA

NA

Winters BR. (2015) [13]

61

M

24.0

Yes

Yes (FOLFOXIRI)

Si

570

350

T4b

N2

M0

IIIC

NA

None

7

NA

NA

Wiliams M. (2020) [14]

46

M

18.1

Yes

Yes (mFOLFOX6)

NA

200

NA

T4

N2a

M1

IV

4.0

UTI (II), ureteric stricture (IIIa)

9

Yes (not local)

21

Stefan S (2022) [15]

62

M

32.0

Yes

Yes (capecitabine)

X

400

100

ypT4b

N1b

MX

ypIIIc

> 1.0

ileus (II) and UTI (II)

11

NA

1

Our case

67

M

19.0

Yes

Yes (tegafur/uracil)

Xi

560

200

ypT4b

N0

M0

ypIIc

2.5

unknown fever (II)

21

None

24

  1. RM; resection margin, UTI; urinary tract infection
  2. Generation of Da Vinci Systems® (Intuitive Surgical, Sunnyvale, CA, USA)
  3. §According to Union for International Cancer Control TNM classification 8th edition